Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05541133 · ClinicalTrials.gov registry record
Effect of Acute Exercise on Exosome Associated Biomarkers
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 12
- Enrollment target
NCT05541133: Completed study, sponsored by Mayo Clinic.
NCT05541133 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05541133 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This research study is being done to understand the underlying mechanism by which exercise affects the body on the cellular level, in an acute aerobic endurance setting. This may help to better understand the overall benefits of endurance exercise.
Primary Outcome
Exosome proteomes and MiRNA from blood samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2024-12-31 |
What the finished NCT05541133 record still lists
NCT05541133 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05541133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05541133 about?
NCT05541133 is a clinical study titled "Effect of Acute Exercise on Exosome Associated Biomarkers". This research study is being done to understand the underlying mechanism by which exercise affects the body on the cellular level, in an acute aerobic endurance setting. This may help to better understand the overall benefits of endurance exercise.
What is the current status of trial NCT05541133?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2022-06-21. Estimated completion is 2024-12-31.
Who is sponsoring clinical trial NCT05541133?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI